Haleon (LON:HLN) Trading Down 1.2%

Haleon plc (LON:HLN) shares dropped 1.2% on Thursday . The company traded as low as GBX 322.20 ($4.08) and last traded at GBX 322.20 ($4.08). Approximately 10,019,905 shares were traded during trading, a decline of 51% from the average daily volume of 20,297,662 shares. The stock had previously closed at GBX 326.10 ($4.12).

Analyst Ratings Changes

HLN has been the subject of a number of analyst reports. Barclays cut their price target on Haleon from GBX 390 ($4.93) to GBX 383 ($4.84) and set an “overweight” rating for the company in a research note on Tuesday, April 9th. HSBC began coverage on Haleon in a research report on Thursday, April 18th. They set a “buy” rating for the company.

Haleon Stock Down 1.2 %

The company has a quick ratio of 0.93, a current ratio of 1.04 and a debt-to-equity ratio of 57.42. The company has a market capitalization of £29.42 billion and a PE ratio of 2,685.00. The company’s 50 day moving average is GBX 327.74 and its two-hundred day moving average is GBX 326.03.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.